Adial Pharmaceuticals, Inc (ADIL) Social Stream
ADIAL PHARMACEUTICALS INC (ADIL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ADIAL PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-29 | 3 | $14.6 | $5 | $10.533 | $1.58 | 566.65% |
| 2022-03-30 | 3 | $15 | $5 | $11.65 | $1.58 | 637.34% |
| 2022-06-15 | 3 | $15 | $5 | $10.666 | $1.58 | 575.06% |
| 2022-07-21 | 3 | $15 | $3 | $8.666 | $1.58 | 448.48% |
| 2022-08-18 | 3 | $9 | $9 | $9 | $1.58 | 469.62% |
| 2022-10-03 | 3 | $9 | $8.001 | $8.5 | $1.58 | 437.97% |
| 2022-11-23 | 3 | $9 | $8 | $8.5 | $1.58 | 437.97% |
| 2023-03-30 | 3 | $9 | $6 | $7.5 | $1.58 | 374.68% |
| 2023-05-18 | 3 | $150 | $150 | $150 | $1.58 | 9393.67% |
| 2023-08-21 | 2 | $150 | $33 | $91.5 | $1.58 | 5691.14% |
| 2023-08-24 | 3 | $33 | $8 | $20.5 | $1.58 | 1197.47% |
| 2023-10-25 | 3 | $26 | $8 | $17 | $1.58 | 975.95% |
The Trend in the Analyst Price Target
ADIL's average price target has moved up $12 over the prior 47 months.
ADIL reports an average of 7,458.33% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-01 | 3 | 6 | 6 | 6.0 | 0.330 | 1718.18% |
| 2023-05-10 | 3 | 6 | 6 | 6.0 | 0.327 | 1734.86% |
| 2023-05-18 | 2 | 150 | 150 | 150.0 | 0.324 | 46196.3% |
| 2023-08-21 | 2 | 150 | 33 | 91.5 | 3.350 | 2631.34% |
| 2023-10-25 | 3 | 26 | 8 | 17.0 | 2.110 | 705.69% |
ADIL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 35 months, ADIL's average broker recommendation rating worsened by 0.67.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ADIL has a higher upside potential (average analyst target price relative to current price) than 1618.93% of all US stocks.
- In the context of all US stocks, ADIAL PHARMACEUTICALS INC's number of analysts covering the stock is greater than 106.83% of them.
- ADIL has a lower variance in analysts' estimates than -854.53% of all US stocks.
- In terms of how ADIAL PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 515.83% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADIAL PHARMACEUTICALS INC are XCUR, ASLN, and COCP.
View All Top Stocks by Price Target
What is the outlook for ADIL? Use POWR Ratings for clearer insight into price direction.